Dermatologic ultrasound imaging has been rapidly growing in recently years [1,2]. Currently, ultrasonography (US) studies for superficial fibromatoses, palmar fibromatosis, namely Dupuytren's disease [3] and plantar disease, namely Ledderhose disease [4] which are located in the subcutaneous tissue have been described in ultrasound field. Dupuytren's disease is a routine for the dermatologist, because patient with subcutaneous nodule may firstly visit a dermatologist. In this review, the author provides an update on the characteristic US appearances in superficial fibromatoses, palmar and plantar diseases.
Dermatological UltrasoundThe international working group, namely DERMUS (Dermatologic Ultrasound) was formed and provided the guidelines [1] and proposed for an assessment training program [2]. Currently, US reports for palmar fibromatosis, namely Dupuytren's disease [3]and plantar disease, namely Ledderhorse disease [4] which are soft tissue tumors have been described in ultrasound field. We usually perform US studies for dermatologic fields with a high-resolution, broad-band (5MHz-18MHz) linear transducer (Nobulus Hitachi, Ltd.Tokyo, Japan). We have also provided several reports of the dermatologic lesion [5][6][7][8][9][10][11][12][13][14][15][16].
Normal Skin ElasticityThe author has previously described anatomy in dermatological ultrasound [16]. Klauser et al. [17] suggested that red is used to represent softer tissues, blue represents harder tissues, and yellow or green represent intermediate tissue elasticity on sonoelastography. The dermis consisting of connective tissue, nerves, blood, and lymphatic vessels, gland, mast cells, fibroblasts, histiocytes [18] represents blue color, showing hard nature, namely, low elasticity. While the subcutaneous fat tissue shows red color, consistent with soft nature, suggesting high elasticity, and reflecting contents of adipose cells [18] on RTE. Yang et al. [19] also studied a reference range of normal skin elasticity evaluated by share wave elastography (SWE) in healthy subjects to interpret results in patients with systemic scleroderma. They described that